chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 10:01 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Feb-2021 at 10:01 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 36.74.  Concomitant products were not provided.  On 12-Feb-2021, Excursion time was 09 AM, 10 AM and 11 AM temperature was 29, 35 and 35, total doses given for the day was 162, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Feb-2021, vial was moved to clinic on 12-Feb-2021. 03 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Client received j&j 03/11/2021.They then received  a moderna booster on 10/28/2021. Her doctor then advised her to go and get another booster as j&j was not an effective option and wanted the patient to have a full dose of Moderna to be considered fully vaccinated .
Starting on 6/19 in the middle of the night, baby developed fever ~ 101 which responded to tylenol. Continued fever through 6/20 but rising up to 103 and more irritable. Admitted to ER overnight 6/20 due to persistent high fever in 2 month old. Full Rule out sepsis done with lumbar puncture, blood culture, urine testing and started empiric antibiotics.  Respiratory viral panel negative. Persistent fever despite negative CSF/ Blood/ urine and antibiotics. On 6/20 into 6/21 also developed rash on body and on palms and soles.  On 6/21 overnight into 6/22 with non-purulent conjunctivitis and peeling red lips. Tuesday 6/22 diagnosed with Kawasaki disease. Treated with IVIG and Aspirin for Kawasaki with immediate improvement in fever and irritability. Discharged on aspirin for 6 weeks
This spontaneous report has been received from a nurse practitioner referring to an unspecified number of patients of unknown age and gender. The patient's medical history, drug reactions, concomitant therapies or allergies were not provided. On an unknown date, the patients were vaccinated with an improperly stored dose of M-M-R II (route of administration, dose, albumin status, and anatomical location were not provided) lot# K024825, expiration date 02-DEC-2016. No adverse event was reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Neck and upper back pain. Seen in ED on 1/7/21, symptoms improved with muscle relaxer.
Past lot that had been expired, administered to patient; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient) and NO ADVERSE EVENT (No adverse event) in a 73-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient).    NDC ID number was reported as 80777027398.  Patient age was reported as 73 years and 04 months.  Concomitant product use was not provided by the reporter.  Reportedly, the number of patients at facility that received this Moderna vaccine between 08-Apr-2022 and 15-Dec-2022. Additionally, In the second list, reporter discovered a past lot that had also been expired and administered to patients with batch number as 065F21A.  Treatment information was not provided.
first dose on September 2021, only first administrated; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 68-year-old male patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (received 1st dose 7th September 2021 with batch no gg3s5, expiry date 28th February 2022).   On an unknown date, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist reported that the patient was late for the second dose of Twinrix.  Till the time of reporting, the patient did not receive 2nd dose of Twinrix, which led to incomplete course of vaccination. No adverse event was reported . The reporter did not consent to follow-up.
Was sitting on exam table when Medical Asst. noticed her eyes looked unfocused and her face became pale. Did not lose consciousness. Medical Asst. laid patient down on exam table, and recovered after just a few minutes.
numbness and tingling in both hands. after 5 minutes it spread to her body, tongue and lips. Maybe after an hour, left side of face was numb for a little while. Today, feel ok, except left hand still feels the same.
This prospective pregnancy case was reported by a health care professional and described the occurrence of vaccine exposure during pregnancy in a 28-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). The subject's medical history included 1 previous full-term pregnancy. On 21 May 2014, the subject received an unspecified dose of BOOSTRIX (Intramuscular, administration site unknown). The last menstrual period was on 26 October 2013 and estimated date of delivery was on 2 August 2014. The subject was exposed to the vaccine during the 3rd trimester. At the time of reporting, the pregnancy was ongoing. Follow-up information received on 4 August 2014: Subject's details and report details were provided. Follow-up information received on 30 October 2014: On 29 July 2014, the patient gave birth to a female infant at 39 3/7 weeks of gestation by cesarean section. Birth weight was 8 lbs and APGAR scores at 1 minute and 5 minutes were 08 and 09.
maybe it was vasovagal episode; tingling all over; arm was sore; dizziness gotten worse; tachycardia right after vaccine about 10 minutes after; This spontaneous case was reported by a physician and describes the occurrence of TACHYCARDIA (tachycardia right after vaccine about 10 minutes after), PRESYNCOPE (maybe it was vasovagal episode), PARAESTHESIA (tingling all over), PAIN IN EXTREMITY (arm was sore) and DIZZINESS (dizziness gotten worse) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced TACHYCARDIA (tachycardia right after vaccine about 10 minutes after). On an unknown date, the patient experienced PRESYNCOPE (maybe it was vasovagal episode), PARAESTHESIA (tingling all over), PAIN IN EXTREMITY (arm was sore) and DIZZINESS (dizziness gotten worse). The patient was treated with MOMETASONE FUROATE (NASONEX) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (tachycardia right after vaccine about 10 minutes after), PRESYNCOPE (maybe it was vasovagal episode), PARAESTHESIA (tingling all over), PAIN IN EXTREMITY (arm was sore) and DIZZINESS (dizziness gotten worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Numbness, tingling/crawling sensation in left leg, 2 days after vaccine  Immediate day of and after muscle soreness, chills, left arm intense pain and headache
Nausea; This is an initial spontaneous report from a contactable reporter (Physician). This contactable reporter reported for a 44-year-old male patient that:  A 44-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 15Mar2021 (at the age of 44-year-old) as dose 1 single for covid-19 immunisation. Medical history included neoplasm of left kidney from 2007 to an unknown date. Patient had no known allergies. It was unknown that prior to vaccination, patient diagnosed with COVID-19. The patient's concomitant medications were not reported. Patient was not received any other vaccine four weeks prior vaccination and it was unknown that patient receive any medication two weeks prior vaccination. The patient experienced nausea on 15Mar2021. It was unknown that since the vaccination, patient been tested for COVID-19. Adverse Event resulted to visit Doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. The outcome of the event was reported as not recovered.   Information about lot/batch number has been requested.
Within 12 hours, malaise, dizziness, chills, chattering teeth.  On 11/16, SOB and tachycardia all day.  My normal HR averages around 55 bpm, all day long on 11/16 my resting rate was 90's and low 100's.
Pt stated she got a tetanus shot to her left arm Wednesday and is having arm pain worse with movement and the pain is radiating to the shoulder/neck/axilla area. No recent injury or trauma.  No recent lifting.  Negative recent fever.  Negative nausea, vomiting, diarrhea.  The pain feels muscular. Patient is stable, well appearing, nontoxic, afebrile.
Period immediately after first shot was late by a week and only lasted 2 days.; Period immediately after first shot was late by a week and only lasted 2 days.; Really terrible mood swings; Vaginal wetness has increased too; Emotional more than usual.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0175), via an unspecified route of administration in the left arm on 22Apr2021 at 09:30 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any known allergies. The patient did not receive any other medications in two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 26Apr2021, the patient experienced period immediately after the first shot was late by a week and only lasted 2 days. The patient had really terrible mood swings, emotional more than usual, vaginal wetness has increased too. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events period immediately after first shot was late by a week and only lasted 2 days, really terrible mood swings, emotional more than usual, vaginal wetness has increased too were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
muscle weakness in the arm; ranging from a slight fever (99.8); some body aches; This spontaneous case was reported by a patient and describes the occurrence of MUSCULAR WEAKNESS (muscle weakness in the arm), PYREXIA (ranging from a slight fever (99.8)) and MYALGIA (some body aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concomitant products included CALCIUM for an unknown indication.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (muscle weakness in the arm), PYREXIA (ranging from a slight fever (99.8)) and MYALGIA (some body aches). At the time of the report, MUSCULAR WEAKNESS (muscle weakness in the arm), PYREXIA (ranging from a slight fever (99.8)) and MYALGIA (some body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.8 (Slight).         Patient do not had a compromised immune system, and  not taking any medications other than calcium and vitamins. No treatment information was provided   This case was linked to MOD-2022-662883, MOD-2022-662837 (Patient Link).
Began symptoms of numbness of upper right lip and right side of face morning of 09/22/2010. Began blurry vision and unable to close lid, slow blinking of Rt eye 9/23/2010. Rt neck stiff morning of 09/24/2010. Reports symptoms to EHS 9/24/2010. Weakness. backache, and skin clammy noted morning of 09/22/2010.
a few days after the shot I started feeling crappy. I have muscle pain, joint pain, chills, dizziness and weakness.
Sore muscles, extensive sore joints, esp. hip and lower back/right buttock area. Joint discomfort continuous and ongoing.
Muscle aches; Joint aches (in both hands); Headache; neck pain; Chills; Fatigue; body aches; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 (Lot number and expiration date not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. On an unspecified date, the patient experienced muscle aches, joint aches (in both hands), headache, neck pain, chills, fatigue, and body aches. Therapeutic measures were taken as a result of chills and body aches. Patient took treatment Tylenol for the body aches and chills. It was reported that, patient didn't take the temperature, so did not know if had a fever. The outcome of all the events was unknown.   No follow-up attempts are needed. Information about lot/batch number cannot be requested. No further information is expected.
On 01/08/2021 I received the 1st Covid-19 Moderna vaccine at 1:45pm. At 2pm felt a warm feeling go through my body. At 2:10pm My heartrate went up and felt pain go from right arm into my neck. At 2:15pm I stood up and Heart rate went faster and felt it in my head Pulse was 138. At 2:25pm Pulse went to 152 and bounced between 115-140's. At 2:35pm Blood Pressure was 157/110 and  my chest felt tight. I was feeling dizzy. 2:45pm was put in another room, Still I didn't feel well. At 3:15pm moved to another room they did an EKG it showed sinus tachycardia. 3:45pm went home. 4:pm discovered hives. I also got flu like symptoms for 3 days and a lot of pain and swelling of arm. I also got SOB and chest tightness, Which I
35-40 minutes after injections noticed some wheezing which lasted 30 minutes. Then he started breaking out in a rash. Returned to the clinic around 16:30 (shots given around 14:30). Given Benadryl elixir 25mg, waited 30 minutes in the clinic. Rash started to clear, sent home, instructed to take one more 25mg capsule when arrived, then every 4 hours. Seen in the clinic 12/19 - cleared.
injection site swelling; redness; This is a spontaneous report from a Pfizer sponsored program. A contactable female patient of unspecified age received first dose of bnt162b2(Pfizer COVID-19 Vaccine, formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an 19Apr2021 as single dose for COVID-19 immunization.Medical history and concomitant medications were not reported.On an unspecified date, the patient experienced injection site swelling and redness after her first dose.The patient was scheduled to return for her 2nd dose on 10May2021.The patient wants to know if these are serious adverse events. Outcome of the events was unknown.  No follow-up attempts are possible; Information related to batch/Lot number could not be re-quested.
Has had ongoing fatigue, weight gain and brain fog since receiving COVID-19 vaccines. Went to Doctor and had blood drawn and sent to a Urologist. Inconclusive findings.
Side effects; This case was reported by a consumer via call center representative and described the occurrence of adverse event in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per the vaccine indication. The patient received Shingrix and had side effects. The reporter asked would the patient had the side effects the day after the injections. The reporter would contact his/her physician if still felt this way tomorrow.
Dermatographia: Skin irritation and reaction to heat, hot water, or general irritants such as clothing, or abrasions. Once to twice daily allegra and anti-histamine suppresses the reaction, but otherwise, it has been ongoing for 2 months now.
TC from patient with report that she received TC yesterday @ approximately 8:30 a.m. and then @ midnight last night had hot/cold flashes, aching ers, felt like jaw was locking up, jaw popping, nausea, body aches.  States "I felt like I was going to die.:  Also got TB skin test yesterday.  Now has HA, jaw and neck are sore but overall feels much better.  Denies illness at time of shot yesterday.  CHN informed patient that if s/sx worsen, to see PMD or go to ER and not to receive further TC without informing provider of this reaction.  Patient denies previous Td shot because her dad was a chiropractor and didn't believe in shots.  Patient states she got TC for graduate school.
Patient vomited about 2 minutes after receiving flu vaccine. Patient turned pale a little bit, but turned back normal look quickly. Pharmacist checked his pulse, and patient had strong pulse. His chest raised up and down normally. Patient's forehead was warm. He answered questions of pharmacist such as first name, last name, date of birth correctly. Pharmacist asked patient if he could breath and patient said he could breath normally. Patient demonstrated to the pharmacist that he could inhaled and exhaled normally.  Patient yelled at his mother when she tried to clean up his body. Patient was laughing at his siblings when he was sitting for monitoring. Patient was monitoring for about 1 hour before he left with his family. Patient felt completely fine when he left vaccine site.  Pharmacist followed up with the parents of the patient by phone after 5 to 6 hours of accident. The mother said the patient was completely fine.
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history were not provided. On unknown dates the patients were vaccinated with improperly stored doses of ZOSTAVAX (lot # L034736, expiry date: 09-DEC-2016) (route, dose# and site of administration not mentioned by the nurse. The vaccine was stored at -2.0 degree centigrade for a time frame of 12 hours and 10 minutes (incorrect product storage). There was no previous temperature excursion. The call was a result of a "data logger". No adverse effects were reported. No additional information was provided. Product quality complaint was not filed. Additional information is not expected as the reporter did not wish further contact. This is one of the three reports received from the same reporter.
Severe Vertigo, diarrhea, headache, Gastrointestinal discomfort
1/30/06 6MO well visit, DTaP, Hib. 2/9/06 and 2/15/06 called with fussiness and decreased appetite since shots, 2/15/06 mom noticed right eye turning in. 2/17/06 Pediatric opthalomologist. 6 nerve palsy and papilledema. MRI NL, 2/18 ped neuro increased HC, LP with elevated pressure. Transferred care to another pediatrician
Patient received ADACEL vaccination. One day later started to experience chills and body aches without fever. The patient call pharmacy two days later still with same symptoms but starting to feel better. Pharmacy called Dr. Office and reported.